Connect Biopharma Holdings (CNTB) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to 0.82.
- Connect Biopharma Holdings' Equity Ratio changed N/A to 0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82, marking a year-over-year change of. This contributed to the annual value of 0.91 for FY2024, which is 1419.86% up from last year.
- Per Connect Biopharma Holdings' latest filing, its Equity Ratio stood at 0.82 for Q3 2025.
- In the past 5 years, Connect Biopharma Holdings' Equity Ratio registered a high of 0.92 during Q2 2024, and its lowest value of 0.8 during Q4 2023.
- In the last 3 years, Connect Biopharma Holdings' Equity Ratio had a median value of 0.89 in 2023 and averaged 0.87.
- As far as peak fluctuations go, Connect Biopharma Holdings' Equity Ratio skyrocketed by 1419.86% in 2024, and later plummeted by 588.3% in 2025.
- Connect Biopharma Holdings' Equity Ratio (Quarter) stood at 0.8 in 2023, then increased by 14.2% to 0.91 in 2024, then fell by 9.67% to 0.82 in 2025.
- Its last three reported values are 0.82 in Q3 2025, 0.86 for Q2 2025, and 0.89 during Q1 2025.